Your browser doesn't support javascript.
loading
Medication overuse and drug addiction: a narrative review from addiction perspective.
Takahashi, Tatiane Teru; Ornello, Raffaele; Quatrosi, Giuseppe; Torrente, Angelo; Albanese, Maria; Vigneri, Simone; Guglielmetti, Martina; Maria De Marco, Cristiano; Dutordoir, Camille; Colangeli, Enrico; Fuccaro, Matteo; Di Lenola, Davide; Spuntarelli, Valerio; Pilati, Laura; Di Marco, Salvatore; Van Dycke, Annelies; Abdullahi, Ramla Abuukar; Maassen van den Brink, Antoinette; Martelletti, Paolo.
Afiliación
  • Takahashi TT; Headache Research, Wolfson CARD, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 20 Newcomen St, London, SE1 1YR, UK. tati.pharmacy@gmail.com.
  • Ornello R; Present address: Medicines Discovery Catapult, Block 35, Mereside, Alderley Park, Cheshire, SK10 4TG, UK. tati.pharmacy@gmail.com.
  • Quatrosi G; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio 1, Coppito, 67100, L'Aquila, Italy.
  • Torrente A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy.
  • Albanese M; Department of Biomedicine, Neurosciences and Diagnostic (Bi.N.D.), University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
  • Vigneri S; Department of Systems Medicine, University of Rome "Tor Vergata"; Neurology Unit, "Tor Vergata" Hospital, Viale Oxford, 81, 00133, Rome, Italy.
  • Guglielmetti M; Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Via del Vespro, 129, 90127, Palermo, Italy.
  • Maria De Marco C; Pain Medicine Unit, Santa Maria Maddalena Hospital, Occhiobello, Italy.
  • Dutordoir C; Regional Headache Referral Center, Sant'Andrea Hospital, Via di Grottarossa 1039, 00189, Rome, Italy.
  • Colangeli E; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Piazza Università, 21, 07100, Sassari, Italy.
  • Fuccaro M; Regional Headache Referral Center, Sant'Andrea Hospital, Via di Grottarossa 1039, 00189, Rome, Italy.
  • Di Lenola D; Department of Neurology, University Hospital Ghent, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
  • Spuntarelli V; Present address: Medicines Discovery Catapult, Block 35, Mereside, Alderley Park, Cheshire, SK10 4TG, UK.
  • Pilati L; Department of Neurology, Conegliano Hospital, Via Brigata Bisagno, 2, 31015, Conegliano, Italy.
  • Di Marco S; Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Polo Pontino, Viale XXIV Maggio 7, 04100, Latina, Italy.
  • Van Dycke A; Division of Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Centre Rotterdam, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands.
  • Abdullahi RA; Department of Biomedicine, Neurosciences and Diagnostic (Bi.N.D.), University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
  • Maassen van den Brink A; Department of Biomedicine, Neurosciences and Diagnostic (Bi.N.D.), University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
  • Martelletti P; Department of Neurology, AZ Sint-Jan Brugge, Ruddershove 10, 8000, Brugge, Belgium.
J Headache Pain ; 22(1): 32, 2021 Apr 28.
Article en En | MEDLINE | ID: mdl-33910499
ABSTRACT
Chronic headache is particularly prevalent in migraineurs and it can progress to a condition known as medication overuse headache (MOH). MOH is a secondary headache caused by overuse of analgesics or other medications such as triptans to abort acute migraine attacks. The worsening of headache symptoms associated with medication overuse (MO) generally ameliorates following interruption of regular medication use, although the primary headache symptoms remain unaffected. MO patients may also develop certain behaviors such as ritualized drug administration, psychological drug attachment, and withdrawal symptoms that have been suggested to correlate with drug addiction. Although several reviews have been performed on this topic, to the authors best knowledge none of them have examined this topic from the addiction point of view. Therefore, we aimed to identify features in MO and drug addiction that may correlate. We initiate the review by introducing the classes of analgesics and medications that can cause MOH and those with high risk to produce MO. We further compare differences between sensitization resulting from MO and from drug addiction, the neuronal pathways that may be involved, and the genetic susceptibility that may overlap between the two conditions. Finally, ICHD recommendations to treat MOH will be provided herein.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Cefaleas Secundarias / Trastornos Migrañosos Límite: Humans Idioma: En Revista: J Headache Pain Asunto de la revista: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Cefaleas Secundarias / Trastornos Migrañosos Límite: Humans Idioma: En Revista: J Headache Pain Asunto de la revista: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido